Skip to main content

UC Davis Comprehensive Cancer Center

Philip C. Mack, Ph.D. View profile as PDF

Philip C. Mack

Clinical Interests

Dr. Mack conducts molecular biology and molecular pharmacology studies for the UC Davis Cancer Center, the California Cancer Consortium, and the Southwest Oncology Group. For the past twelve years, Dr. Mack has conducted basic and translational research, with an emphasis on lung cancer. His investigations include molecular and cellular effects of novel anticancer agents in lung cancer models. Dr. Mack is Director of the UC Davis Cancer Center Molecular Pharmacology shared resource, Director of Basic Sciences for the California Cancer Consortium and Associate Director of the Southwest Oncology Group Lung Translational Medicine Committee.


Director of Molecular Pharmacology


Cancer, Hematology/Oncology, Molecular Biology/Medicine



Hematology and Oncology


UC Davis Cancer Center


Ph.D., UC Davis, Davis, California, 1997
B.A., UC Santa Cruz, Santa Cruz, California, 1991

Professional Memberships:

American Association for Cancer Research
American Society of Clinical Oncology
International Association for the Study of Lung Cancer
Southwest Oncology Group

Select Honors and Awards:

Helen and Christine Landgraf Memorial Research Fund Award, 2002

Select Recent Publications:

For a comprehensive list of Dr. Mack's publications, please click here (opens new window).